相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PERK, Beyond an Unfolded Protein Response Sensor in Estrogen-Induced Apoptosis in Endocrine-Resistant Breast Cancer
Ping Fan et al.
MOLECULAR CANCER RESEARCH (2022)
50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?
V. Craig Jordan
ENDOCRINE-RELATED CANCER (2021)
Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team
V. Craig Jordan
BREAST CANCER RESEARCH AND TREATMENT (2021)
Cancer Incidence Projections in the United States Between 2015 and 2050
Hannah K. Weir et al.
PREVENTING CHRONIC DISEASE (2021)
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer
Balkees Abderrahman et al.
MOLECULAR CANCER THERAPEUTICS (2021)
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells
Philipp Y. Maximov et al.
MOLECULAR PHARMACOLOGY (2020)
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy
Arkadiusz Z. Dudek et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Molecular Mechanism for Breast Cancer Incidence in the Women's Health Initiative
V. Craig Jordan
CANCER PREVENTION RESEARCH (2020)
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials
Rowan T. Chlebowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Src couples estrogen receptor to the anticipatory unfolded protein response and regulates cancer cell fate under stress
Liqun Yu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
Balkees Abderrahman et al.
MOLECULAR PHARMACOLOGY (2020)
Estrogen therapy induces an unfolded protein response to drive cell death in ER plus breast cancer
Sarah R. Hosford et al.
MOLECULAR ONCOLOGY (2019)
Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells
Ping Fan et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Estrogen-Induced Apoptosis in Breast Cancers Is Phenocopied by Blocking Dephosphorylation of Eukaryotic Initiation Factor 2 Alpha (eIF2α) Protein
Surojeet Sengupta et al.
MOLECULAR CANCER RESEARCH (2019)
Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer
Philipp Y. Maximov et al.
MOLECULAR PHARMACOLOGY (2018)
Targeting Peroxisome Proliferator-Activated Receptor gamma to Increase Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells
Ping Fan et al.
MOLECULAR CANCER THERAPEUTICS (2018)
How PERK kinase conveys stress signals to nuclear factor-κB to mediate estrogen-induced apoptosis in breast cancer cells?
Ping Fan et al.
CELL DEATH & DISEASE (2018)
Modulation of nuclear factor-kappa B activation by the endoplasmic reticulum stress sensor PERK to mediate estrogen- induced apoptosis in breast cancer cells
Ping Fan et al.
CELL DEATH DISCOVERY (2018)
Breast cancer statistics, 2017, racial disparity in mortality by state
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer
Rui Xiong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The modulation of estrogen-induced apoptosis as an interpretation of the women's health initiative trials
Balkees Abderrahman et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2016)
Estrogen Receptor Mutations Found in Breast Cancer Metastases Integrated With the Molecular Pharmacology of Selective ER Modulators
V. Craig Jordan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Integration of Downstream Signals of Insulin-like Growth Factor-1 Receptor by Endoplasmic Reticulum Stress for Estrogen-Induced Growth or Apoptosis in Breast Cancer Cells
Ping Fan et al.
MOLECULAR CANCER RESEARCH (2015)
Estrogen Receptor Mutations Found in Breast Cancer Metastases Integrated With the Molecular Pharmacology of Selective ER Modulators
V. Craig Jordan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death
I. Obiorah et al.
BRITISH JOURNAL OF CANCER (2014)
Differences in the rate of oestrogen-induced apoptosis in breast cancer by oestradiol and the triphenylethylene bisphenol
I. E. Obiorah et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Breast Cancer Cell Apoptosis with Phytoestrogens Is Dependent on an Estrogen-Deprived State
Ifeyinwa E. Obiorah et al.
CANCER PREVENTION RESEARCH (2014)
Molecular Modulation of Estrogen-Induced Apoptosis by Synthetic Progestins in Hormone Replacement Therapy: An Insight into the Women's Health Initiative Study
Elizabeth E. Sweeney et al.
CANCER RESEARCH (2014)
Inhibition of c-Src blocks oestrogen-induced apoptosis and restores oestrogen-stimulated growth in long-term oestrogen-deprived breast cancer cells
Ping Fan et al.
EUROPEAN JOURNAL OF CANCER (2014)
Mechanisms underlying differential response to estrogen-induced apoptosis in long-term estrogen-deprived breast cancer cells
Elizabeth E. Sweeney et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Defining the Conformation of the Estrogen Receptor Complex That Controls Estrogen-Induced Apoptosis in Breast Cancer
Ifeyinwa Obiorah et al.
MOLECULAR PHARMACOLOGY (2014)
Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells
S. Sengupta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
c-Src Modulates Estrogen-Induced Stress and Apoptosis in Estrogen-Deprived Breast Cancer Cells
Ping Fan et al.
CANCER RESEARCH (2013)
Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
Garnet L. Anderson et al.
LANCET ONCOLOGY (2012)
Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time
Eric A. Ariazi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Structure-Function Relationships of Estrogenic Triphenylethylenes Related to Endoxifen and 4-Hydroxytamoxifen
Philipp Y. Maximov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor-Positive, Aromatase Inhibitor-Resistant Advanced Breast Cancer A Phase 2 Randomized Study
Matthew J. Ellis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The 38th David A. Karnofsky lecture: The paradoxical actions of estrogen in breast cancer - Survival or death?
V. Craig Jordan
JOURNAL OF CLINICAL ONCOLOGY (2008)
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer
V. Craig Jordan et al.
STEROIDS (2007)
Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation
JS Lewis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Transcription factor cross-talk:: the estrogen receptor and NF-κB
D Kalaitzidis et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2005)
Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal
JS Lewis et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
RC Coombes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death
J Hitomi et al.
JOURNAL OF CELL BIOLOGY (2004)
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
PE Goss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer - Results of the ATAC (arimidex, tamoxifen alone or in comhination) trial efficacy and safety update analyses
CANCER (2003)
Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17β-estradiol
RXD Song et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
分享论文
